The National Health Services (NHS) in the United Kingdom provides free universal coverage for all residents. Nevertheless, in 2023, ** percent of the population bought supplemental private insurance, this is mostly due to long waiting times in public care. This is the highest percentage reported since 2008, when a percentage of *****was reported.

This statistic displays the share of adults in the United Kingdom (UK) that had private medical insurance (PMI) in 2017, by age groups. Those aged between 45 and 54 were the most likely to have private medical insurance in 2017 with ** percent of insurance covers by that age group. Those aged between 18 and 24 years only made up for * percent of private medical insurance owners.

Market Size and Growth: The UK health and medical insurance market is in a state of steady growth, with a projected CAGR of 4.56% from 2025 to 2033. The market size is estimated to be 8.17 million in 2025, with a value unit of millions. Key drivers behind this growth include rising healthcare costs, increased awareness of health and well-being, and the aging population. Trends and Segments: The market has witnessed several trends, including the growing popularity of private medical insurance, the emergence of healthcare cash plans, and the rise of dental insurance plans. The market is segmented based on product type (private medical insurance, healthcare cash plans, dental insurance plans) and procurement type (self-pay health coverage, employee-sponsored health coverage). Major players in the market include BUPA, AXA PPP, PT Astra Aviva Life, and Freedom Health Insurance. The report provides regional data for North America, South America, Europe, Middle East & Africa, and Asia Pacific. Publisher: [Market Research Company Name] Publish Date: [Month, Year] Number of Pages: [Number] Price: [Amount] The UK Health And Medical Insurance Market report presents a comprehensive analysis of the market including statistics, forecasts, competitive landscape, and trends. The report provides an in-depth look at the market's key segments, including product types, application, and end-user. The report also examines the market's major drivers and challenges and provides insights into the market's future prospects. Recent developments include: On November 2022, in partnership with online platform JAAQ in a six-month trial for boosting access to personalised expert-led health advice online. This adds to Bupa's mental health support which provides ongoing, around-the-clock support for a wealth of mental health conditions, such as anxiety, depression and addiction., On February 2022, AXA UK&I acquired renewable rights to Ageas UK's commercial business at an initial consideration of 47.5 million GBP. This acquisition will strengthen AXA's growth strategy and commitment to its commercial business customers and broker partnerships, particularly in the SME and Schemes market segments. As part of the agreement, around 100 Ageas UK employees will move to AXA Commercial to provide ongoing support and service delivery.. Notable trends are: Global Economic Slowdown and Better Government Insurance Services Affecting the United Kingdom Health and Medical Insurance.

Snapshot img

Health Insurance Market Size 2025-2029

The health insurance market size is forecast to increase by USD 1,341 billion at a CAGR of 7.3% between 2024 and 2029.

The market experiences robust growth, fueled by the increasing demand for comprehensive coverage due to heightened healthcare awareness and a growing emphasis on preventive health. This trend is further driven by the escalating costs of healthcare services and medical treatments, which underscores the importance of insurance as a financial safeguard. However, market expansion encounters significant challenges. Regulatory hurdles impact adoption, as governments and regulatory bodies implement stringent regulations to ensure affordability and accessibility for consumers. Supply chain inconsistencies, such as disparities in provider networks and reimbursement rates, temper growth potential. This is particularly evident in the rising prevalence of chronic conditions such as cancer, stroke, and kidney failure, which necessitate ongoing medication and hospitalization. Additionally, another trend is the shift towards online sales and digital platforms for purchasing insurance policies and accessing healthcare services.
To capitalize on opportunities and navigate challenges effectively, companies must stay informed of regulatory changes and collaborate with healthcare providers to streamline operations and maintain competitive pricing. By focusing on innovation, transparency, and customer-centric solutions, insurers can differentiate themselves in a competitive landscape and meet the evolving needs of health-conscious consumers.

What will be the Size of the Health Insurance Market during the forecast period?

Request Free Sample

In the dynamic market, chronic disease management and mental health coverage have emerged as significant areas of focus. Health insurance networks strive to offer comprehensive solutions, integrating geriatric care, preventive care, and end-of-life care into their offerings. Innovation drives the industry, with wellness programs, home health care, and telemedicine becoming increasingly popular. Compliance with regulations, including those related to maternity care, newborn care, and substance abuse treatment, is crucial.
Specialty care and provider networks continue to shape the landscape, while ethics and claims processing remain critical components of health insurance services. Incorporating mental health coverage into plans and addressing the needs of the aging population are key trends shaping the market.

How is this Health Insurance Industry segmented?

The health insurance industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Service

  Public
  Private


Type

  Life insurance
  Term insurance


Age Group

  Adults
  Senior citizens
  Minors


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

By Service Insights

The public segment is estimated to witness significant growth during the forecast period.

In the dynamic market, various entities play crucial roles in shaping its landscape. Public organizations, such as the National Health Service (NHS) in the UK and Medicare in Australia, are leading providers due to increased government involvement in ensuring universal healthcare access. These programs offer comprehensive coverage, affordable premiums, and a focus on preventive care. Collaborations with commercial insurers, legislative frameworks, and investments in healthcare infrastructure further expand their reach. Quality is a top priority, with health insurance advisors and brokers facilitating the selection of plans that best fit businesses and individuals. Prescription drug coverage is a significant consideration, and self-funded health insurance and health reimbursement arrangements offer flexibility for employers.

Group health insurance and individual health insurance provide different solutions for various needs, with portability ensuring continuity. Health insurance cybersecurity and technology are essential, with health insurance portals, virtual care, and telemedicine transforming the industry. Health savings accounts, flexible spending accounts, and out-of-pocket maximums help manage costs. Managed care and employer-sponsored health insurance are common, with health insurance plans catering to diverse needs. Regulations and compliance are critical, with long-term care insurance addressing specific healthcare requirements. Disability insurance and life insurance provide additional coverage, while the marketing and transparency ensure consumer understanding. Point-of-service (POS) plans and dental/vision insurance offer cu

The UK health and medical insurance market, valued at approximately £8.17 billion in 2025, is projected to experience robust growth, driven by several key factors. Rising healthcare costs, coupled with an aging population and increasing prevalence of chronic diseases, are placing significant pressure on the National Health Service (NHS). This is leading to a surge in demand for private medical insurance (PMI) among individuals and employers seeking faster access to specialist care and shorter waiting times. The market is segmented by product type (Private Medical Insurance – individual and group policies; Healthcare Cash Plans; Dental Insurance Plans) and procurement type (self-pay and employer-sponsored). The growth of employer-sponsored health coverage reflects a trend among businesses to offer competitive benefits packages to attract and retain talent. Furthermore, technological advancements, such as telehealth and digital health platforms, are improving accessibility and efficiency within the sector, fueling further market expansion. Competitive pressures from established players like Bupa, AXA PPP, and Aviva, alongside the emergence of newer entrants, are fostering innovation and driving down costs in specific segments. However, market growth is not without its restraints. Regulatory changes, economic uncertainties, and concerns over affordability, particularly for individual policies, pose challenges to the market's expansion. The increasing cost of premiums, alongside concerns about policy exclusions and limitations, can impact consumer adoption. Despite these challenges, the long-term outlook for the UK health and medical insurance market remains positive. The projected Compound Annual Growth Rate (CAGR) of 4.56% suggests a considerable increase in market value over the forecast period (2025-2033). This growth is likely to be driven primarily by the continued demand for private healthcare solutions, supplemented by ongoing technological advancements and an evolving regulatory landscape that shapes both competition and consumer access. Recent developments include: On November 2022, in partnership with online platform JAAQ in a six-month trial for boosting access to personalised expert-led health advice online. This adds to Bupa's mental health support which provides ongoing, around-the-clock support for a wealth of mental health conditions, such as anxiety, depression and addiction., On February 2022, AXA UK&I acquired renewable rights to Ageas UK's commercial business at an initial consideration of 47.5 million GBP. This acquisition will strengthen AXA's growth strategy and commitment to its commercial business customers and broker partnerships, particularly in the SME and Schemes market segments. As part of the agreement, around 100 Ageas UK employees will move to AXA Commercial to provide ongoing support and service delivery.. Notable trends are: Global Economic Slowdown and Better Government Insurance Services Affecting the United Kingdom Health and Medical Insurance.

In 2023, about *********** people in Great Britain had private health and medical insurance with BUPA, an increase compared to the previous year. Aviva and AXA Health were the next most popular insurance brands.

The statistic shows the number of individuals covered by a private health insurance in the United Kingdom (UK) from 2002 to 2011. In 2011, the number of individuals covered by a private health insurance was 5.8 millions.

The UK teeth insurance market, while part of a larger global market projected to reach a significant value by 2033, shows substantial growth potential. Driven by increasing awareness of dental health, rising costs of dental procedures, and an aging population requiring more extensive care, the market is experiencing steady expansion. The prevalence of dental plans offered through employers and privately, across segments such as DHMO, DPPO, and DIP, contributes to this growth. However, factors like high premiums and limited coverage for certain procedures can act as restraints. We anticipate the most significant growth within the adult and senior citizen demographics, reflecting increased demand for preventative and major dental work. Within the UK, specific regional variations in market penetration may exist, with higher adoption in urban areas compared to rural regions. The competitive landscape involves both established international players like Cigna and Bupa, and smaller, localized providers, creating a dynamic market with opportunities for both consolidation and innovation. Future growth will likely depend on developing more affordable plans, emphasizing preventative care to reduce long-term costs, and tailoring products to meet the specific needs of different age groups and income brackets. The increasing adoption of digital technologies in dental practice management and insurance administration could also present new opportunities for market expansion. The UK market exhibits a fragmented nature, with several providers offering varied plans. Given the global CAGR of 5%, and assuming a slightly higher growth rate for the UK market due to its advanced healthcare system and relatively high disposable incomes, we can estimate a robust growth trajectory. This growth will be influenced by government policies regarding dental care accessibility and insurance regulations. The focus on preventative care is likely to be a major driver, leading to increased uptake of dental insurance among the younger population as well. Expansion opportunities lie in offering customized plans that appeal to specific needs, such as plans focused solely on preventative care for younger adults or comprehensive coverage for seniors. The industry's continued growth will hinge on strategic partnerships between dental providers and insurance companies to improve access and affordability, and a continued public education campaign highlighting the long-term financial benefits of dental insurance. This comprehensive report provides a detailed analysis of the UK teeth insurance market, covering the period from 2019 to 2033. It offers invaluable insights into market size, growth drivers, challenges, and future trends, making it an essential resource for industry stakeholders, investors, and researchers. The report leverages extensive data analysis, incorporating high-search-volume keywords such as "dental insurance UK," "private dental insurance cost," "best dental insurance plans," and "UK dental cover," to ensure maximum online visibility. Recent developments include: In May 2022, Simplyhealth, the UK's largest health, and dental plan provider announced an investment in Ampersand, a supplier of digital therapeutics for inflammatory diseases. This partnership will aid in the implementation of digital treatments in the United Kingdom, minimizing outpatient appointments, increasing health outcomes, and lowering unexpected hospital stays for patients suffering from a variety of inflammatory diseases., In January 2021, Unum Dental gave its policy members an Amazon e-voucher in recognition that they could not access surgeries or use some of their policy benefits while dental practices were closed during the first national lockdown.. Notable trends are: Raising Consumer Price Index for Dental Services in UK.

According to a survey conducted in the United Kingdom (UK) in 2021, ** percent respondents stated that they were likely to pay for private health insurance or private healthcare because they are able to access care or treatment more quickly. Furthermore, ** percent of people said they were likely to pay for private health insurance because they think the quality of care or treatment is better.

The Organisation for Economic Co-operation and Development (OECD) Health Statistics offers the most comprehensive source of comparable statistics on health and health systems across OECD countries. It is an essential tool for health researchers and policy advisors in governments, the private sector and the academic community, to carry out comparative analyses and draw lessons from international comparisons of diverse health care systems. Within UKDS.Stat the data are presented in the following databases:

Health status

This datasets presents internationally comparable statistics on morbidity and mortality with variables such as life expectancy, causes of mortality, maternal and infant mortality, potential years of life lost, perceived health status, infant health, dental health, communicable diseases, cancer, injuries, absence from work due to illness. The annual data begins in 2000.

Non-medical determinants of health

This dataset examines the non-medical determinants of health by comparing food, alcohol, tobacco consumption and body weight amongst countries. The data are expressed in different measures such as calories, grammes, kilo, gender, population. The data begins in 1960.

Healthcare resources

This dataset includes comparative tables analyzing various health care resources such as total health and social employment, physicians by age, gender, categories, midwives, nurses, caring personnel, personal care workers, dentists, pharmacists, physiotherapists, hospital employment, graduates, remuneration of health professionals, hospitals, hospital beds, medical technology with their respective subsets. The statistics are expressed in different units of measure such as number of persons, salaried, self-employed, per population. The annual data begins in 1960.

Healthcare utilisation

This dataset includes statistics comparing different countries’ level of health care utilisation in terms of prevention, immunisation, screening, diagnostics exams, consultations, in-patient utilisation, average length of stay, diagnostic categories, acute care, in-patient care, discharge rates, transplants, dialyses, ICD-9-CM. The data is comparable with respect to units of measures such as days, percentages, population, number per capita, procedures, and available beds.

Health Care Quality Indicators

This dataset includes comparative tables analyzing various health care quality indicators such as cancer care, care for acute exacerbation of chronic conditions, care for chronic conditions and care for mental disorders. The annual data begins in 1995.

Pharmaceutical market

This dataset focuses on the pharmaceutical market comparing countries in terms of pharmaceutical consumption, drugs, pharmaceutical sales, pharmaceutical market, revenues, statistics. The annual data begins in 1960.

Long-term care resources and utilisation

This dataset provides statistics comparing long-term care resources and utilisation by country in terms of workers, beds in nursing and residential care facilities and care recipients. In this table data is expressed in different measures such as gender, age and population. The annual data begins in 1960.

Health expenditure and financing

This dataset compares countries in terms of their current and total expenditures on health by comparing how they allocate their budget with respect to different health care functions while looking at different financing agents and providers. The data covers the years starting from 1960 extending until 2010. The countries covered are Australia, Austria, Belgium, Canada, Chile, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Japan, Korea, Luxembourg, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom, and United States.

Social protection

This dataset introduces the different health care coverage systems such as the government/social health insurance and private health insurance. The statistics are expressed in percentage of the population covered or number of persons. The annual data begins in 1960.

Demographic references

This dataset provides statistics regarding general demographic references in terms of population, age structure, gender, but also in term of labour force. The annual data begins in 1960.

Economic references

This dataset presents main economic indicators such as GDP and Purchasing power parities (PPP) and compares countries in terms of those macroeconomic references as well as currency rates, average annual wages. The annual data begins in 1960.

These data were first provided by the UK Data Service in November 2014.

The European pet insurance market, valued at €3.39 billion in 2025, is experiencing robust growth, projected to expand at a Compound Annual Growth Rate (CAGR) of 9.36% from 2025 to 2033. This expansion is driven by several key factors. Increasing pet ownership across Europe, coupled with rising pet humanization and a greater willingness to invest in pet healthcare, are significant contributors. Consumers are increasingly recognizing the financial burden of unexpected veterinary expenses, leading to a higher demand for comprehensive coverage. The market is further fueled by the introduction of innovative insurance products, including lifetime coverage options and specialized plans for different animal types (dogs, cats, etc.), catering to diverse pet owner needs and preferences. The growth is also being propelled by the expansion of distribution channels, with online sales and partnerships with veterinary clinics playing a pivotal role in market penetration. However, the market faces certain restraints. Pricing remains a key concern for many potential customers, particularly those with multiple pets or older animals. Competition among established players and new entrants is also intensifying, requiring insurers to continuously enhance their product offerings and customer service. Regulatory changes and variations in insurance regulations across different European countries can also pose challenges for market expansion and standardization. Despite these challenges, the long-term outlook for the European pet insurance market remains positive, driven by the increasing pet population, growing awareness of pet insurance benefits, and the continued innovation within the industry. The increasing availability of digital tools and services further promises to enhance customer experience and accelerate market growth. Germany, the UK, and France are expected to remain the leading markets within Europe. Recent developments include: February 2023: The new brand Agria Petinsure, formerly Petinsure, is entering the Irish market with a clear mission. Currently, the insurance rate for dogs in the Irish market is approximately 10%-15%, while the rate for cats is approximately 5%. It is estimated that 90% of dogs and 50% of cats in Sweden have pet insurance. Agria Petinsure believes that the same safety should be available for all Irish pets, and pet owners should enjoy peace of mind if their pet needs medical treatment., November 2022: Pet insurance provider Trupanion has entered into an agreement to acquire Royal Blue s.r.o., the parent company of PetExpert. This acquisition will be the second in Europe for Trupanion, following the acquisition of Smart Paws.. Notable trends are: Increasing trend of Dog Insurance Premiums in Europe.

Snapshot img

Healthcare Cloud Computing Market Size 2024-2028

The healthcare cloud computing market size is valued to increase by USD 98.6 billion, at a CAGR of 31.52% from 2023 to 2028. Integrated service offerings for healthcare will drive the healthcare cloud computing market.

Market Insights

North America dominated the market and accounted for a 47% growth during the 2024-2028.
By Product - SaaS segment was valued at USD 7.60 billion in 2022
By Component - Hardware segment accounted for the largest market revenue share in 2022

Market Size & Forecast

Market Opportunities: USD 966.13 billion 
Market Future Opportunities 2023: USD 98.60 billion
CAGR from 2023 to 2028 : 31.52%

Market Summary

The market is experiencing significant growth as the global healthcare industry increasingly embraces digital transformation. Cloud computing offers numerous benefits, including scalability, cost savings, and improved data security. One key driver of this trend is the need for operational efficiency and regulatory compliance in healthcare. For instance, a large hospital network may use cloud computing to streamline its supply chain management, enabling real-time inventory tracking and automated reordering of essential medical supplies. Another trend shaping the healthcare cloud computing landscape is the introduction of edge computing. Edge computing allows data processing to occur closer to the source, reducing latency and improving data security. This is particularly important in healthcare, where real-time data processing can mean the difference between life and death. However, the healthcare industry faces unique challenges in implementing cloud computing solutions. The shortage of cloud professionals with expertise in healthcare IT is a significant barrier to adoption. This skills gap can lead to delays in implementation and increased costs. Despite these challenges, the benefits of cloud computing in healthcare are too substantial to ignore. As the industry continues to evolve, we can expect to see more innovative applications of cloud computing technology, from telemedicine to population health management.

What will be the size of the Healthcare Cloud Computing Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free SampleThe market continues to evolve, offering innovative solutions for various sectors, including care coordination, clinical trial management, and pharmacovigilance systems. One significant trend is the digital health transformation, which enables value-based care models and improves patient outcomes through data visualization dashboards and real-time data insights. Operational efficiency gains are another essential benefit, with companies reporting up to 30% reduction in processing time. Cloud computing security remains a priority, ensuring data privacy and protection through advanced encryption methods, access control, and machine learning applications. Wearable sensor data and precision medicine initiatives are revolutionizing patient care, while deep learning algorithms and computer vision applications streamline physician workflow and medical device integration. Population health management and workflow optimization are also crucial areas of focus, as healthcare organizations strive for improved patient engagement and cost reduction. In summary, the market offers numerous advantages, from enhanced care coordination and clinical trial management to operational efficiency gains and real-time data insights. By embracing cloud computing solutions, healthcare organizations can improve patient outcomes, streamline workflows, and reduce costs, all while maintaining the highest levels of data privacy and security.

Unpacking the Healthcare Cloud Computing Market Landscape

In the dynamic healthcare landscape, cloud computing has emerged as a game-changer, offering significant advantages over traditional on-premises systems. Virtual care delivery through cloud-based telemedicine platforms has seen a 30% increase in patient engagement, enabling remote access to medical services and improving patient outcomes. Data encryption algorithms ensure patient data security, while risk management strategies and cybersecurity protocols safeguard sensitive information. Predictive analytics models and AI-powered diagnostics enhance clinical decision support, driving ROI improvement by up to 25%. Cloud storage, compliant with HIPAA regulations, facilitates medical image archiving and health data exchange. Serverless computing, high-availability systems, and API integration in healthcare enable scalable infrastructure and streamlined workflows. Data governance frameworks and access control systems ensure compliance auditing and data de-identification methods protect patient privacy. Additionally, microservices architecture, containerization technologies, blockchain healthcare,

Flu vaccine uptake (percent) in at risk individuals aged 6 months to 65 years (excluding pregnant women), who received the flu vaccination between 1st September to the end of February as recorded in the GP record. The February collection has been adopted for our end of season figures from 2017 to 2018. All previous data is the same definitions but until the end of January rather than February to consider data returning from outside the practice and later in practice vaccinations.RationaleInfluenza (also known as Flu) is a highly infectious viral illness spread by droplet infection. The flu vaccination is offered to people who are at greater risk of developing serious complications if they catch the flu. The seasonal influenza programme for England is set out in the Annual Flu Letter. Both the flu letter and the flu plan have the support of the Chief Medical Officer (CMO), Chief Pharmaceutical Officer (CPhO), and Director of Nursing.Vaccination coverage is the best indicator of the level of protection a population will have against vaccine-preventable communicable diseases. Immunisation is one of the most effective healthcare interventions available, and flu vaccines can prevent illness and hospital admissions among these groups of people. Increasing the uptake of the flu vaccine among these high-risk groups should also contribute to easing winter pressure on primary care services and hospital admissions. Coverage is closely related to levels of disease. Monitoring coverage identifies possible drops in immunity before levels of disease rise.The UK Health Security Agency (UKHSA) will continue to provide expert advice and monitoring of public health, including immunisation. NHS England now has responsibility for commissioning the flu programme, and GPs continue to play a key role. NHS England teams will ensure that robust plans are in place locally and that high vaccination uptake levels are reached in the clinical risk groups. For more information, see the Green Book chapter 19 on Influenza.The Annual Flu Letter sets out the national vaccine uptake ambitions each year. In 2021 to 2022, the national ambition was to achieve at least 85 percent vaccine uptake in those aged 65 and over. Prior to this, the national vaccine uptake ambition was 75 percent, in line with WHO targets.Definition of numeratorNumerator is the number of vaccinations administered during the influenza season between 1st September and the end of February.Definition of denominatorDenominator is the GP registered population on the date of extraction including patients who have been offered the vaccine but refused it, as the uptake rate is measured against the overall eligible population. For more detailed information please see the user guide, available to view and download from https://www.gov.uk/government/collections/vaccine-uptake#seasonal-flu-vaccine-uptakeCaveatsRead codes are primarily used for data collection purposes to extract vaccine uptake data for patients who fall into one or more of the designated clinical risk groups. The codes identify individuals at risk, and therefore eligible for flu vaccination. However, it is important to note that there may be some individuals with conditions not specified in the recommended risk groups for vaccination, who may be offered influenza vaccine by their GP based on clinical judgement and according to advice contained in the flu letter and Green Book, and thus are likely to fall outside the listed Read codes. Therefore, this data should not be used for GP payment purposes.

In 2020, the share of daily nursing home costs that are handled by public authorities or insurances varies greatly from one European country to another. How European countries regulate nursing home costs depends on their public health expense policies. Long-term care is a significant part of a country’s healthcare expenditure. To a certain extent, health costs and medical expenses are financed by local authorities, national or regional health insurance, and national nursing care insurance. In Ireland, ** percent of the cost per day of a nursing home was borne by the financial support derived from the Fair Deal Scheme. In Czechia, only ** percent of the daily nursing home costs were supported by health insurance. The complex landscape of European nursing homes In 2020, the landscape of nursing homes in Europe was diverse with different shares of homes owned by public or private institutions. During that year, over ** percent of nursing homes were publicly owned in Norway and Denmark. Within privately owned homes, some were for-profit and others not. For instance, ** percent of nursing homes were owned by for-profit private companies in the UK, whereas ** percent of nursing homes were owned by the private non-profit sector in the Netherlands. Therefore, the share of nursing home beds managed by the public or private sector was also very different from one European country to another. The costs of nursing homes in Europe In 2019, the average daily cost of a care home could reach over *** euros in some European countries and less than ** euros in others. During that year, the average monthly cost of a care home amounted to **** euros in the United Kingdom and Germany. The cost of care homes is expected to increase as the need will escalate in Europe due to its aging population. Nonetheless, European health systems rely significantly on informal care, a potentially risky strategy.

In 2023, Singapore dominated the ranking of the world's health and health systems, followed by Japan and South Korea. The health index score is calculated by evaluating various indicators that assess the health of the population, and access to the services required to sustain good health, including health outcomes, health systems, sickness and risk factors, and mortality rates. The health and health system index score of the top ten countries with the best healthcare system in the world ranged between 82 and 86.9, measured on a scale of zero to 100.

Global Health Security Index  Numerous health and health system indexes have been developed to assess various attributes and aspects of a nation's healthcare system. One such measure is the Global Health Security (GHS) index. This index evaluates the ability of 195 nations to identify, assess, and mitigate biological hazards in addition to political and socioeconomic concerns, the quality of their healthcare systems, and their compliance with international finance and standards. In 2021, the United States was ranked at the top of the GHS index, but due to multiple reasons, the U.S. government failed to effectively manage the COVID-19 pandemic. The GHS Index evaluates capability and identifies preparation gaps; nevertheless, it cannot predict a nation's resource allocation in case of a public health emergency.

Universal Health Coverage Index  Another health index that is used globally by the members of the United Nations (UN) is the universal health care (UHC) service coverage index. The UHC index monitors the country's progress related to the sustainable developmental goal (SDG) number three. The UHC service coverage index tracks 14 indicators related to reproductive, maternal, newborn, and child health, infectious diseases, non-communicable diseases, service capacity, and access to care. The main target of universal health coverage is to ensure that no one is denied access to essential medical services due to financial hardships. In 2021, the UHC index scores ranged from as low as 21 to a high score of 91 across 194 countries. 

Among OECD countries in 2023, South Korea had the highest rate of yearly visits to a doctor per capita. On average, South Koreans visited the doctors 15.7 times per year in person. Health care utilization is an important indicator of the success of a country’s health care system. There are many factors that affect health care utilization including healthcare structure and the supply of health care providers. OECD health systems Healthcare systems globally include a variety of tools for accessing healthcare, including private insurance based systems, like in the U.S., and universal systems, like in the U.K. Health systems have varying costs among the OECD countries. Worldwide, Europe has the highest expenditures for health as a proportion of the GDP. Among all OECD countries, The United States had the one of the highest share of government spending on health care. Recent estimates of current per capita health expenditures showed the United States also had, by far, the highest per capita spending on health worldwide. Supply of health providers Globally, the country with the highest physician density is Cuba, although most other countries with high number of physicians to population was found in Europe. The number of graduates of medicine impacts the number of available physicians in countries. Among OECD countries, Latvia had the highest rate of graduates of medicine, which was almost twice the rate of the OECD average.

Among OECD member countries, the United States had the ******* percentage of gross domestic product spent on health care as of 2024. The U.S. spent nearly **** percent of its GDP on health care services. Germany, Austria, and Germany followed the U.S. with distinctly smaller percentages. The United States had both significantly higher private and public spending on health compared with other developed countries. Why compare OECD countries? OECD stands for Organization for Economic Co-operation and Development. It is an economic organization consisting of 38 members, mostly high-income countries and committed to democratic principles and market economy. This makes OECD statistics more comparable than statistics of developed and undeveloped countries. Health economics is an important matter for the OECD, even more since increasing health costs and an aging population have become an issue for many developed countries. Health costs in the U.S. A higher GDP share spent on health care does not automatically lead to a better functioning health system. In the case of the U.S., high spending is mainly because of higher costs and prices, not due to higher utilization. For example, physicians’ salaries are much higher in the U.S. than in other comparable countries. A doctor in the U.S. earns more than ***** as much as the average physician in Germany. Pharmaceutical spending per capita is also distinctly higher in the United States. Furthermore, the U.S. also spends more on health administrative costs compared to other wealthy countries.

The number of people in the Philippines choosing to get life insurance significantly increased between 2016 and 2023. From merely ** million in 2016, this figure has reached close to ** million in 2023. Despite this, the penetration rate of the insurance industry in the country remained lower than the global average. Life insurance in the Philippines The ratio of the total insurance premiums to the population, or insurance density, was several times higher for life insurance than for non-life insurance in the Philippines. Individuals are more likely to get a life insurance policy as it provides financial protection to the family or beneficiaries of the insured in comparison to non-life insurance. There are two types of life insurance available: traditional and variable. Traditional life insurance focuses more on death or living benefits, whereas variable insurance policies are investment-linked insurance of a broader nature. As of 2023, traditional life insurance companies in the Philippines earned premium income amounting to approximately ***** billion Philippine pesos, which was significantly higher compared to 2016. In the same year, Sun Life of Canada (Philippines) and Pru Life Insurance Corporation (UK) were the two leading life insurance companies in the Philippines. Challenges to insurance penetration The Philippine economy has been poised for growth in recent years, with its middle-class population characterized by rising disposable incomes. However, this has not made significant contributions to the insurance industry in the Philippines, which remains to have one of the lowest penetration rates globally. Among the possible reasons for this have been low awareness and the affordability of insurance plans, especially among low-income households.